ArticlePloS one2026
Mask - Region-based Convolutional Neural Networks (R-CNN) with Radiomics Integration and Gray Level Co-occurrence Matrix (GLCM) for brain tumor detection and segmentation.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Machine Learning for Radiomics in Oncology: Challenges, Limitations, and Future Directions.Sensors (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early diagnosis of brain tumors is important for successful treatment and better patient consequences in industrial information systems. This research employs Mask Region-based Convolutional Neural Networks (R-CNN), radiomics integration, and the Gray Level Co-occurrence Matrix (GLCM) to progress brain tumor detection and segmentation using Magnetic Resonance Imaging (MRI) images. The Mask R-CNN is employed to precisely label tumor regions of interest (ROIs) by precisely segmenting pixels. Radiomic features in the form of texture, shape, and intensity measures are calculated on the segmented ROIs to provide a numerical estimate of tumor heterogeneity. Meanwhile, GLCM-based texture features are computed to derive the fine-scale spatial classifications of pixel intensities in tumor regions, which may provide more information regarding tumor structure. Such handcrafted features are merged with deep features obtained with the help of the Mask R-CNN architecture to form a strong feature set that takes the benefits of both classical radiomics and deep learning (DL). The combination of the feature set is classified using a detection head multilayer perceptron (MLP) to predict the presence and the nature of a tumor. The experimental results on an experimental brain tumor MRI dataset proved that the proposed approach is better than independent Mask R-CNN and radiomics-based approaches. The model is very sensitive, specific and precise in differentiating between glioma, meningioma, pituitary adenoma and non-tumor cases. The feasibility of this hybrid solution is the combination of handcrafted and deep features to further the brain tumor detection that provides medical practitioners with a handy tool of detecting brain tumors early and accurately.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.